PMV Pharmaceuticals, Inc.
PMVP
$1.56
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.35% | 0.71% | -21.64% | 24.19% | -19.63% |
| Total Depreciation and Amortization | 6.45% | -3.13% | -13.51% | -5.13% | -89.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.91% | -28.69% | 44.01% | -86.24% | 482.83% |
| Change in Net Operating Assets | -97.51% | -72.73% | 224.69% | -206.23% | 22.15% |
| Cash from Operations | 13.27% | -8.29% | -0.20% | -9.63% | 1.06% |
| Capital Expenditure | -1,600.00% | 109.09% | -175.00% | 92.86% | -5,500.00% |
| Sale of Property, Plant, and Equipment | -100.00% | -96.67% | -- | -- | 665.52% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.49% | 9.66% | -61.81% | 278.97% | -55.66% |
| Cash from Investing | 53.34% | 9.48% | -61.74% | 270.79% | -54.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 930.00% | -94.19% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | 930.00% | -94.19% | -- |
| Foreign Exchange rate Adjustments | -150.00% | 300.00% | -114.29% | 163.64% | -375.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.13% | -7.98% | -168.93% | 219.52% | -3,183.10% |